OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: A systematic review and meta-analysis
Thomas Karagiannis, Απόστολος Τσάπας, Eleni Athanasiadou, et al.
Diabetes Research and Clinical Practice (2021) Vol. 174, pp. 108737-108737
Closed Access | Times Cited: 97
Thomas Karagiannis, Απόστολος Τσάπας, Eleni Athanasiadou, et al.
Diabetes Research and Clinical Practice (2021) Vol. 174, pp. 108737-108737
Closed Access | Times Cited: 97
Showing 1-25 of 97 citing articles:
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1158
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetes Care (2022) Vol. 45, Iss. 11, pp. 2753-2786
Open Access | Times Cited: 1158
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 675
Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 1925-1966
Open Access | Times Cited: 675
A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 3567-3602
Open Access | Times Cited: 293
Josh Reed, Stephen C. Bain, Venkateswarlu Kanamarlapudi
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 3567-3602
Open Access | Times Cited: 293
13. Older Adults: Standards of Medical Care in Diabetes—2022
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S195-S207
Open Access | Times Cited: 173
Diabetes Care (2021) Vol. 45, Iss. Supplement_1, pp. S195-S207
Open Access | Times Cited: 173
13. Older Adults: Standards of Care in Diabetes—2023
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S216-S229
Open Access | Times Cited: 153
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, et al.
Diabetes Care (2022) Vol. 46, Iss. Supplement_1, pp. S216-S229
Open Access | Times Cited: 153
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD
Chandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. 29-38
Open Access | Times Cited: 120
Chandani Patel Chavez, Kenneth Cusi, Sushma Kadiyala
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 1, pp. 29-38
Open Access | Times Cited: 120
Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus
Juan José Gorgojo Martínez, Pedro Mezquita‐Raya, Juana Carretero Gómez, et al.
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 145-145
Open Access | Times Cited: 101
Juan José Gorgojo Martínez, Pedro Mezquita‐Raya, Juana Carretero Gómez, et al.
Journal of Clinical Medicine (2022) Vol. 12, Iss. 1, pp. 145-145
Open Access | Times Cited: 101
13. Older Adults: Standards of Care in Diabetes—2024
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S244-S257
Open Access | Times Cited: 83
Nuha A. ElSayed, Grazia Aleppo, Raveendhara R. Bannuru, et al.
Diabetes Care (2023) Vol. 47, Iss. Supplement_1, pp. S244-S257
Open Access | Times Cited: 83
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study
Maria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, et al.
Pharmacological Research (2022) Vol. 183, pp. 106396-106396
Closed Access | Times Cited: 39
Maria Elena Lunati, Vincenzo Cimino, Alessandra Gandolfi, et al.
Pharmacological Research (2022) Vol. 183, pp. 106396-106396
Closed Access | Times Cited: 39
Socioeconomic aspects of incretin-based therapy
Thomas Karagiannis, Eleni Bekiari, Απόστολος Τσάπας
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1859-1868
Open Access | Times Cited: 30
Thomas Karagiannis, Eleni Bekiari, Απόστολος Τσάπας
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1859-1868
Open Access | Times Cited: 30
The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care
Giuseppina Russo, Paolo Di Bartolo, Riccardo Candido, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110672-110672
Closed Access | Times Cited: 27
Giuseppina Russo, Paolo Di Bartolo, Riccardo Candido, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110672-110672
Closed Access | Times Cited: 27
13. Older Adults: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S266-S282
Closed Access | Times Cited: 12
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S266-S282
Closed Access | Times Cited: 12
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Lixin Guo, Xinhua Xiao
Aging Medicine (2024) Vol. 7, Iss. 1, pp. 5-51
Open Access | Times Cited: 9
Lixin Guo, Xinhua Xiao
Aging Medicine (2024) Vol. 7, Iss. 1, pp. 5-51
Open Access | Times Cited: 9
2022 update to the position statement by Primary Care Diabetes Europe: a disease state approach to the pharmacological management of type 2 diabetes in primary care
Samuel Seidu, Xavier Cos, Stephen Brunton, et al.
Primary care diabetes (2022) Vol. 16, Iss. 2, pp. 223-244
Open Access | Times Cited: 31
Samuel Seidu, Xavier Cos, Stephen Brunton, et al.
Primary care diabetes (2022) Vol. 16, Iss. 2, pp. 223-244
Open Access | Times Cited: 31
Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases
Wei Peng, Rui Zhou, Zefang Sun, et al.
Aging and Disease (2022) Vol. 13, Iss. 2, pp. 468-468
Open Access | Times Cited: 30
Wei Peng, Rui Zhou, Zefang Sun, et al.
Aging and Disease (2022) Vol. 13, Iss. 2, pp. 468-468
Open Access | Times Cited: 30
Efficacy and safety profile of SGLT2 inhibitors in the elderly: How is the benefit/risk balance?
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20
André Scheen, Fabrice Bonnet
Diabetes & Metabolism (2023) Vol. 49, Iss. 2, pp. 101419-101419
Open Access | Times Cited: 20
Metabolic Impact of Frailty Changes Diabetes Trajectory
Alan J. Sinclair, Ahmed H. Abdelhafiz
Metabolites (2023) Vol. 13, Iss. 2, pp. 295-295
Open Access | Times Cited: 16
Alan J. Sinclair, Ahmed H. Abdelhafiz
Metabolites (2023) Vol. 13, Iss. 2, pp. 295-295
Open Access | Times Cited: 16
Old age as a risk factor for liver diseases: Modern therapeutic approaches
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva
Experimental Gerontology (2023) Vol. 184, pp. 112334-112334
Open Access | Times Cited: 14
Milena Georgieva, Charilaos Xenodochidis, Natalia Krasteva
Experimental Gerontology (2023) Vol. 184, pp. 112334-112334
Open Access | Times Cited: 14
Individualizing Care for Older Adults With Diabetes Amid the Revolution in Pharmacotherapy
Elbert S. Huang
JAMA Internal Medicine (2024) Vol. 184, Iss. 4, pp. 435-435
Open Access | Times Cited: 5
Elbert S. Huang
JAMA Internal Medicine (2024) Vol. 184, Iss. 4, pp. 435-435
Open Access | Times Cited: 5
Evaluation of glucose-lowering medications in older people: a comprehensive systematic review and network meta-analysis of randomized controlled trials
Ssu-Yu Pan, En-Lin Su, Chi‐Jung Huang, et al.
Age and Ageing (2024) Vol. 53, Iss. 8
Closed Access | Times Cited: 5
Ssu-Yu Pan, En-Lin Su, Chi‐Jung Huang, et al.
Age and Ageing (2024) Vol. 53, Iss. 8
Closed Access | Times Cited: 5
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies
André Scheen
Diabetes & Metabolism (2023) Vol. 49, Iss. 5, pp. 101474-101474
Closed Access | Times Cited: 11
André Scheen
Diabetes & Metabolism (2023) Vol. 49, Iss. 5, pp. 101474-101474
Closed Access | Times Cited: 11
Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: Systematic review and meta-analysis
Anika Bilal, Fanchao Yi, Gonzalo Romero Gonzalez, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 8, pp. 108783-108783
Open Access | Times Cited: 4
Anika Bilal, Fanchao Yi, Gonzalo Romero Gonzalez, et al.
Journal of Diabetes and its Complications (2024) Vol. 38, Iss. 8, pp. 108783-108783
Open Access | Times Cited: 4
Early combination therapy with SGLT2i and GLP ‐1 RA or dual GIP /GLP ‐1 RA in type 2 diabetes
Catarina Vale, Inês Mariana Lourenço, Gabriela Jordan, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 468-481
Closed Access | Times Cited: 4
Catarina Vale, Inês Mariana Lourenço, Gabriela Jordan, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 468-481
Closed Access | Times Cited: 4
The Use of SGLT-2 Inhibitors and GLP-1RA in Frail Older People with Diabetes: A Personalised Approach Is Required
Alan J. Sinclair, Ahmed H. Abdelhafiz
Metabolites (2025) Vol. 15, Iss. 1, pp. 49-49
Open Access
Alan J. Sinclair, Ahmed H. Abdelhafiz
Metabolites (2025) Vol. 15, Iss. 1, pp. 49-49
Open Access
Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor Agonists
Yuan-Hsin Chen, Thomas M. Zink, Ya‐Wen Chen, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250081-e250081
Open Access
Yuan-Hsin Chen, Thomas M. Zink, Ya‐Wen Chen, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250081-e250081
Open Access
